159 related articles for article (PubMed ID: 22431319)
21. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
Sullivan PS; Apple SK
Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
[TBL] [Abstract][Full Text] [Related]
22. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
Shield PW; Koivurinne K
Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions.
Lee JS; Nam JH; Lee MC; Park CS; Juhng SW
Acta Cytol; 1996; 40(4):631-6. PubMed ID: 8693877
[TBL] [Abstract][Full Text] [Related]
24. E-cadherin expression in primary carcinomas of the breast and its distant metastases.
Kowalski PJ; Rubin MA; Kleer CG
Breast Cancer Res; 2003; 5(6):R217-22. PubMed ID: 14580257
[TBL] [Abstract][Full Text] [Related]
25. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
[TBL] [Abstract][Full Text] [Related]
26. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
27. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
29. Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications.
Davidson B; Risberg B; Berner A; Nesland JM; Tropé CG; Kristensen GB; Bryne M; Goscinski M; van de Putte G; Flørenes VA
Gynecol Oncol; 2001 Nov; 83(2):249-56. PubMed ID: 11606079
[TBL] [Abstract][Full Text] [Related]
30. Cytology of fluids from pleural, peritoneal and pericardial cavities in children. A comprehensive survey.
Hallman JR; Geisinger KR
Acta Cytol; 1994; 38(2):209-17. PubMed ID: 8147212
[TBL] [Abstract][Full Text] [Related]
31. [A comparative study of metastatic patterns of ductal and lobular carcinoma of the breast from two matched series (376 patients)].
Fondrinier E; Guérin O; Lorimier G
Bull Cancer; 1997 Dec; 84(12):1101-7. PubMed ID: 9587361
[TBL] [Abstract][Full Text] [Related]
32. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
[TBL] [Abstract][Full Text] [Related]
33. Ultrastructural studies of cells in body cavity effusions.
Bewtra C; Greer KP
Acta Cytol; 1985; 29(3):226-38. PubMed ID: 3859122
[TBL] [Abstract][Full Text] [Related]
34. Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocks.
Kim JH; Kim GE; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
Diagn Cytopathol; 2009 Apr; 37(4):258-61. PubMed ID: 19217030
[TBL] [Abstract][Full Text] [Related]
35. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Berner HS; Tropè CG; Kristensen GB; Bryne M; Ann Florenes V
J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863
[TBL] [Abstract][Full Text] [Related]
36. Heparanase expression correlates with poor survival in metastatic ovarian carcinoma.
Davidson B; Shafat I; Risberg B; Ilan N; Trope' CG; Vlodavsky I; Reich R
Gynecol Oncol; 2007 Feb; 104(2):311-9. PubMed ID: 17030350
[TBL] [Abstract][Full Text] [Related]
37. The metabolic behaviour of the cellular populations in the pleural or peritoneal effusions from patients with malignant diseases.
Mihăilescu E; Micu D; Cheţa N; Chiriloiu C; Georgescu M; Vilău C
Med Interne; 1986; 24(3):227-33. PubMed ID: 2430328
[TBL] [Abstract][Full Text] [Related]
38. Detection of c-Ha-ras oncogene expression in pleural and peritoneal smear effusions by in situ hybridization.
Athanassiadou PP; Veneti SZ; Kyrkou KA; Athanassiades PH
Cancer Detect Prev; 1993; 17(6):585-90. PubMed ID: 8275510
[TBL] [Abstract][Full Text] [Related]
39. Glucose transporter Glut-1 is of limited value for detecting breast carcinoma in serous effusions.
Zimmerman RL; Goonewardene S; Fogt F
Mod Pathol; 2001 Aug; 14(8):748-51. PubMed ID: 11504833
[TBL] [Abstract][Full Text] [Related]
40. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]